Slightly higher glucagon levels during hypoglycemia in the GLP-1 group compared to the control experiments were previously found in studies with native GLP-1 [29], with the GLP-1 analogue exenatide [10] and the the DPP-IV inhibitor vildagliptin [30]. This evidence concerns the gene GCG and Hypoglycemia.